Crossmark

Live Birth Rates in Women Under 38 Years Old with AMH Level < 1.2 ng/ml in the First In Vitro Fertilization + / − Intracytoplasmic Sperm Injection: Retrospective Study and Arguments for Care

Crossref DOI link: https://doi.org/10.1007/s43032-022-01091-x

Published Online: 2022-09-29

Published Print: 2023-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Morcel, Karine

Merviel, Philippe https://orcid.org/0000-0003-0184-0880
Pertuisel, Diane

James, Pandora

Bouée, Sarah

Le Guillou, Mathilde

Chabaud, Jean-Jacques

Roche, Sylvie

Drapier, Hortense

Perrin, Aurore

Beauvillard, Damien
License Information

Text and Data Mining valid from 2022-09-29

Version of Record valid from 2022-09-29
More Information

Article History

Received: 1 August 2022

Accepted: 16 September 2022

First Online: 29 September 2022

Declarations

:

: All the subjects have signed consent to the infertility treatment (ART French legislation). For this study, an informed consent was obtained from all subjects and/or their legal guardians, and was approved by the Brest Institutional Review Board as an ancillary study of the authorization obtained on 2020 June 18 (reference B2020CE.43).The consents of each subject are available in their medical record and with the corresponding author.

: The manuscript has been read and approved by all authors. The authors confirm that all methods were carried out in accordance with relevant guidelines and regulations.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below